Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

Completed

Phase N/A Results

Summary of Purpose

To assess the effect of a prophylactic regimen with low-dose calcium heparin on the morbidity from deep-vein thrombosis and the mortality from pulmonary emboli.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Chest Heart and Stroke Association, Oxford locally organized research funds, Labaz & Evans Biologicals Ltd.

Trial Design

Randomized, controlled trial of 305 patients at 2 centers.

Contacts

Not available